Kevin Walsh - Profile and Investment Details

Investor Profile

Kevin Walsh is a Venture Capital, Private Equity Firm, Venture Debt based in Pleasanton, California, United States with a diverse investment portfolio that includes companies such as CSA Medical, Aerin Medical, Titan Pharmaceuticals, GenePeeks, Bridge2 Solutions, New Haven Pharmaceuticals, IntelePeer, Alula Holdings, PebblePost, OutboundEngine, SpringCM, ScoreBig, Getaround, IntegenX, SilkRoad Technology, Nomi, Intarcia Therapeutics, Conventus OrthopaedicsMederi Therapeutics, Audacy, Copan Systems, ZetrOZ, Mustang Bio, Ambit Biosciences, Mblox, SavingStar, Ontrak, Medsphere Systems, Castle Creek Biosciences, MacuLogix, Avalanche Technology, Interleukin Genetics, NinePoint Medical, New Signature, IgnitionOne, Meditrina, Inc, Corinth MedTech, Ceribell, Digital Signal, Palatin Technologies, Canary Medical, InVisage Technologies, Grab Media, Topia, Radisphere Radiology, Social Intelligence, Valore, Overture Networks, Argos Therapeutics, Encore Dermatology, Receptiv, AccuVein, . Over time, Kevin Walsh has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Kevin Walsh is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Advertising, Health Care, Cybersecurity, Wellness, Women Founded, Enterprise Software, Investment Management, HR Tech, Design, Transportation, Android, Life Science, Portfolio Management, Marketplace, Internet of Things (IoT), Email Marketing, Venture Fundraising, Collaborative Consumption, Mobile, Technology, Finance, Software, Biotechnology, Clinical Trials, FinTech, Employee Benefits, PeertoPeer, Ride Sharing, Marketing, Social Media, Health Diagnostics, Medical, SaaS, Big Data, B2B, Media and Entertainment, Pharmaceuticals, Risk Management may find it worthwhile to explore potential connections with Kevin Walsh, as their portfolio suggests a familiarity and interest in this area.

Understanding Kevin Walsh’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.